Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It has been used for decades to treat these conditions, but like all medications, there is a risk of overdose. In this article, we will discuss the dangers of clonidine overdose, how to recognize the signs and symptoms, and how to avoid it.
Clonidine is a prescription medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It is usually taken as a pill, but can also be taken as a patch or liquid.
Clonidine overdose can be dangerous and even fatal. Signs and symptoms of a clonidine overdose may include: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression. In severe cases, an overdose can lead to coma and death.
It is important to be aware of the signs and symptoms of a clonidine overdose. If you or someone you know is taking clonidine and is exhibiting any of the following symptoms, seek medical attention immediately: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
The best way to avoid a clonidine overdose is to take the medication as prescribed by your doctor. Do not take more than the recommended dose and do not take it more often than prescribed.
Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. While it is effective in treating these conditions, there is a risk of overdose. The dangers of clonidine overdose include confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
1.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
2.
A paper strip test might enable the early detection of cancer.
3.
Breast cancer patients' arms swell less after an effective lymph node transfer.
4.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
5.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
1.
CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target
2.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
3.
Seeing the Unseen: Examining Chancroid Through Images
4.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation